As you may be aware, the Cross-Network TB Vaccine Working Group (TB Vaccine WG) Leadership are in the process of planning a multiday virtual meeting to develop a TB vaccine roadmap research for people living with HIV (PLWHIV), which will outline the current TB vaccine landscape and determine where TB vaccine research is headed. The meeting will be held in partnership with NIH/DAIDS. Attendees will include representatives from various organizations including members of the Cross-Network TB Vaccine Working Group, representatives from the WHO, stringent and local regulators (FDA, EMA...

The HU CFAR is well aware that Dr. Galit Alter is an unprecedented collaborator and now everyone knows.

Boston Globe articles: https://www.bostonglobe.com/2020/12/10/magazine/2020-bostonians-year/

"Government service was never part of my plans. But every doctor knows that when a patient is coding, your plans don’t matter. You run to the code. And when a nation is coding—if you are called to serve, you serve." .... Rochelle Walensky

MGH's Rochelle Walensky to run CDC
https://news.harvard.edu/gazette/story/2020/12/mass-general-hospitals-rochelle-walensky-to-run-cdc/

Who is Rochelle Walensky:
https://www.npr.org/2020/12/09/944739752/who-is-rochelle-walensky-bidens-pick-for-cdc-director

Unafraid to speak her mind:
https://www.washingtonpost....

Congratulations to the Harvard investigators and teams that have recieved NIH funding for the following trials units and networks:

Read about the NIH structuring of Clinical Trials Networks:
...

The Harvard University Center for AIDS Research (HU CFAR) announced recently that Rajesh Gandhi and Galit Alter have taken on the positions of co-directors, with Gandhi assuming the additional title of principal investigator.

Gandhi and Alter are succeeding Bruce Walker, Harvard professor and director of the Ragon Institute of Massachusetts General Hospital (MGH), MIT, and Harvard. Walker served as director for more than 25 years and his leadership shaped the CFAR into the successful Center it is today.

Full article in the Gazette: ...

AIDS Application Due Dates:  March 17, 2021; March 17, 2022; March 17, 2023

See full details: Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed)

Purpose: to support innovative, collaborative, interdisciplinary early-stage research to inform the development of innovative rapid, sensitive, simple, and cost-effective...

Download Event Flyer

View Speaker Biographies

Watch the event recording: 

...

View the Symposium Agenda
View the Speaker Biographies
Watch this "...

View Flyer:

https://cfar.globalhealth.harvard.edu/files/cfar/files/fostering_diversity_in_hiv_research_program_mentee_application.pdf?m=1601401275

To apply, please visit:...

See full details:
Investigaion the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional)

Please note the first receipt date is DECEMBER 15, 2020.